Has anyone go info on the potential market for NTCell?
Patients in US = 500,000 to 1,500,000 with 50,000 to 60,000 new cases reported annually.

80,000 in Aus. 9,000 annually.

Any idea of treatment costs and COGS? Has this been discussed?

Thanks.